Nidanilimab (Anti-IL-1RAP / IL-1R3)

製品コード：A2444         Batch: A244401

印刷

Nidanilimab (Anti-IL-1RAP / IL-1R3) is a fully humanized monoclonal antibody targeting IL1RAP and blocks IL1α and IL1β signaling. It also stimulates the immune system to destroy tumour cells. It can be used in treatment of non-small lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC). MW :143.56 KD.

製品説明

CAS No. 2171061-85-9
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Isotype Human IgG1
Source CHO
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Shipping Shipped under low temperature conditions
Purity 99%
Protein concentration 4.52mg/ml
Endotoxin Level ＜1EU/mg

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

Placenta-derived factors contribute to human iPSC-liver organoid growth [ Nat Commun, 2025, 16(1):2493] PubMed: 40082402
Single-nucleus and spatial landscape of the sub-ventricular zone in human glioblastoma [ bioRxiv, 2024, 2024.04.24.590852] PubMed: 38712234

人間や獣医の診断であるか治療的な使用のためにでない。